Fig. 1From: Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemicOverlap between common factors which promote an unfavorable cardio-metabolic profile in women with polycystic ovary syndrome (PCOS) and factors which, based on the existing data, appear to increase the risk for severe COVID-19 (*further research is required to clarify the potential links between adverse COVID-19-related outcomes and hyper-cytokinemia, hyperandrogenemia, and vitamin D deficiency)Back to article page